For covered patients with advanced, metastatic cancer, plans would have to cover certain approved medicines without requiring a different drug to fail first.
Covered plans would not be allowed to require patients to try a different drug first before covering certain research-backed medicines for advanced, metastatic cancer or related conditions.
Covered health plans would not be allowed to require patients to try a different drug before covering certain medicines. This applies to plans that cover advanced, metastatic cancer and related symptoms or treatment side effects that a health practitioner judges could further harm the patient if untreated. The drug must be approved by the FDA, fit best practices for advanced, metastatic cancer or a related condition, and be supported by peer-reviewed, evidence-based research. The bill would take effect after publication in the statute book.
No hearings or votes scheduled.